INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,736,752 | -20.4% | 848,800 | -52.5% | 0.37% | -13.6% |
| Q2 2023 | $19,780,312 | +12596.9% | 1,788,455 | +15317.7% | 0.43% | +14333.3% |
| Q1 2023 | $155,788 | +8.6% | 11,600 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $143,492 | -97.9% | 11,600 | -97.7% | 0.00% | -98.3% |
| Q3 2022 | $6,956,000 | +725.1% | 498,600 | +716.3% | 0.17% | +690.9% |
| Q2 2022 | $843,000 | -87.2% | 61,079 | -84.9% | 0.02% | -85.8% |
| Q4 2021 | $6,606,000 | +415.3% | 405,494 | +369.9% | 0.16% | +342.9% |
| Q3 2021 | $1,282,000 | -51.3% | 86,300 | +321.0% | 0.04% | -96.5% |
| Q1 2016 | $2,634,000 | – | 20,500 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |